This provides up to an additional $11,375 beyond the standard DRG payment for the procedure, according to a news relese. It’s available at facilities that provide inpatient care for spinal stenosis and spondylolisthesis.
The TOPS System earned the FDA’s breakthrough technology designation in 2020 and granted PMA approval in June. The system is an alternative to lumbar spinal fusion for patients with spinal stenosis and spondylolisthesis.
Recent data supported the cost-effectiveness of the system.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
